1. Crosstalk between Beclin-1-dependent autophagy and caspase-dependent apoptosis induced by tanshinone IIA in human osteosarcoma MG-63 cells
    Kun Ma et al, 2016 CrossRef
  2. STAT3 but Not HIF-1α Is Important in Mediating Hypoxia-Induced Chemoresistance in MDA-MB-231, a Triple Negative Breast Cancer Cell Line
    Hoda Soleymani Abyaneh et al, 2017, Cancers CrossRef
  3. Phytotherapy and Nutritional Supplements on Breast Cancer.
    C M Lopes et al, 2017, Biomed Res Int CrossRef
  4. Role of phytochemicals in the inhibition of epithelial–mesenchymal transition in cancer metastasis
    Eun-Kyung Kim et al, 2016, Food Funct. CrossRef
  5. TanshinoneIIA enhances the chemosensitivity of breast cancer cells to doxorubicin through down-regulating the expression of MDR-related ABC transporters
    Kun Li et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  6. Tanshinone IIA enhances chemosensitivity of colon cancer cells by suppressing nuclear factor-κB
    YANGQIU BAI et al, 2016 CrossRef
  7. Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial–Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1α
    Jiang Qian et al, 2018, BioMed Research International CrossRef
  8. Ferrous glycinate regulates cell energy metabolism by restrictinghypoxia-induced factor-1α expression in human A549 cells
    Yung-Ting Kuo et al, 2018, Free Radical Research CrossRef
  9. Current Report of Natural Product Development against Breast Cancer Stem Cells
    Adam Hermawan et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
  10. Tanshinone II A improves distribution and anti-tumor efficacy of pegylated liposomal doxorubicin via normalizing the structure and function of tumor vasculature in hepa1-6 hepatoma mice model
    Zhang Ying et al, 2018, Journal of Traditional Chinese Medicine CrossRef
  11. Tanshinone IIA induces intrinsic apoptosis in osteosarcoma cells both in vivo and in vitro associated with mitochondrial dysfunction
    Sheng-Teng Huang et al, 2017, Sci. Rep. CrossRef
  12. Monitoring the Early Response of Fulvestrant Plus Tanshinone IIA Combination Therapy to Estrogen Receptor-Positive Breast Cancer by Longitudinal 18F-FES PET/CT
    SiMin He et al, 2019, Contrast Media & Molecular Imaging CrossRef
  13. Dual Effects of Chinese Herbal Medicines on Angiogenesis in Cancer and Ischemic Stroke Treatments: Role of HIF-1 Network
    Ming Hong et al, 2019, Front. Pharmacol. CrossRef
  14. Expression of Hypoxia-inducible Factor Prolyl Hydroxylase 3 HIFPH3 in Human Non-small Cell Lung Cancer (NSCLC) and Its Correlation with Prognosis
    Xiao Chu et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
  15. Multiple pro-apoptotic targets of abietane diterpenoids from Salvia species
    M. Akaberi et al, 2015, Fitoterapia CrossRef
  16. Salvianolic acid A shows selective cytotoxicity against multidrug-resistant MCF-7 breast cancer cells
    Xin Wang et al, 2015, Anti-Cancer Drugs CrossRef
  17. null
    Da Cheng Hao et al, 2015 CrossRef
  18. Danshen Improves Survival of Patients With Breast Cancer and Dihydroisotanshinone I Induces Ferroptosis and Apoptosis of Breast Cancer Cells
    Yu-Shih Lin et al, 2019, Front. Pharmacol. CrossRef
  19. Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis
    Ying Jiang et al, 2019, International Immunopharmacology CrossRef
  20. Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia
    Devarajan Nalini et al, 2019, J Cancer Res Clin Oncol CrossRef
  21. Metabolite profiling of traditional Chinese medicine XIAOPI formula: An integrated strategy based on UPLC-Q-Orbitrap MS combined with network pharmacology analysis
    Neng Wang et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  22. Aloe-emodin inhibits HER-2 expression through the downregulation of Y-box binding protein-1 in HER-2-overexpressing human breast cancer cells
    Jui-Wen Ma et al, 2016, Oncotarget CrossRef
  23. Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseases
    Zhibei Li et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  24. Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
    Xiaozhong Liao et al, 2020, Front. Oncol. CrossRef
  25. Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance
    Dimas Carolina Belisario et al, 2020, Cells CrossRef
  26. Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons
    Muhlis Akman et al, 2021, J Exp Clin Cancer Res CrossRef
  27. Tanshinone IIA: A Review of its Anticancer Effects
    Zhong‐ying Fang et al, 2021, Front. Pharmacol. CrossRef
  28. Tanshinone ⅡA inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition and protects bovine endometrial epithelial cells from pyolysin-induced damage by modulating the NF-κB/Snail2 signaling pathway
    Kaiqiang Fu et al, 2021, Theriogenology CrossRef
  29. Anticancer Effect of Tanshinones on Female Breast Cancer and Gynecological Cancer
    Zhou Jin et al, 2022, Front. Pharmacol. CrossRef
  30. Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine
    Wenfeng Zhang et al, 2022, Am. J. Chin. Med. CrossRef
  31. Salvia miltiorrhiza in Breast Cancer Treatment: A Review of Its Phytochemistry, Derivatives, Nanoparticles, and Potential Mechanisms
    Huan Zhao et al, 2022, Front. Pharmacol. CrossRef
  32. Dihydrotanshinone I Enhances Cell Adhesion and Inhibits Cell Migration in Osteosarcoma U−2 OS Cells through CD44 and Chemokine Signaling
    Lanyan Fan et al, 2022, Molecules CrossRef
  33. Meta analysis of bioactive compounds, miRNA, siRNA and cell death regulators as sensitizers to doxorubicin induced chemoresistance
    Sruthi Sritharan et al, 2022, Apoptosis CrossRef
  34. Tanshinone IIA reverses oxaliplatin resistance in colorectal cancer through microRNA-30b-5p/AVEN axis
    Tingrui Ge et al, 2022 CrossRef
  35. Tanshinone IIA regulates expression of glucose transporter 1 via activation of the HIF‑1α signaling pathway
    Yanyun Zhou et al, 2022, Mol Med Rep CrossRef